Download PDF
Gastroenterologie up2date 2019; 15(04): 317-319
DOI: 10.1055/a-1026-0859
Studienreferate
Georg Thieme Verlag KG Stuttgart · New York

Aufruf zur endoskopischen Überwachung fortgeschrittener präneoplastischer Läsionen des Magens

Further Information

Publication History

Publication Date:
02 December 2019 (online)

Also available at
    Permissions and Reprints All articles of this category
 

  • Literatur

  • 1 de Vries AC, van Grieken NC, Looman CW. et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-952
    CrossrefPubMedGoogle Scholar
  • 2 Pimentel-Nunes P, Libânio D, Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365-388
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Hassan C, Zullo A, Di Giulio E. et al. Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. Helicobacter 2010; 15: 221-226
    CrossrefPubMedGoogle Scholar
  • 4 Areia M, Dinis-Ribeiro M, Rocha Goncalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter 2014; 19: 425-436
    CrossrefPubMedGoogle Scholar
  • 5 de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007; 12: 1-15
    PubMedGoogle Scholar
  • 6 den Hollander WJ, Holster IL, den Hoed CM. et al. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut 2019; 68: 585-593
    CrossrefPubMedGoogle Scholar
  • 7 Capelle LG, de Vries AC, Haringsma J. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71: 1150-1158
    CrossrefPubMedGoogle Scholar
  • 8 Dinis-Ribeiro M, Areia M, de Vries AC. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Bornschein J, Dingwerth A, Selgrad M. et al. Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions. Eur J Gastroenterol Hepatol 2015; 27: 492-500
    CrossrefPubMedGoogle Scholar
  • 10 Leja M, Funka K, Janciauskas D. et al. Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol 2013; 25: 694-699
    CrossrefPubMedGoogle Scholar
  • 11 Isajevs S, Liepniece-Karele I, Janciauskas D. et al. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch 2014; 464: 403-407
    CrossrefPubMedGoogle Scholar
  • 12 Rugge M, Genta RM, Fassan M. et al. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients. Am J Gastroenterol 2018; 113: 1621-1628
    CrossrefPubMedGoogle Scholar
  • 13 Rugge M, Meggio A, Pravadelli C. et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut 2019; 68: 11-17
    CrossrefPubMedGoogle Scholar